World’s Largest Dietary Intervention Study of Cocoa Flavanols Investigates Long-Term Cardiovascular Health Benefits

You are here

Tuesday, May 12, 2015

Ancillary Studies Focus on Potential Benefits of Cocoa Flavanols on Brain Health

GERMANTOWN, May 12, 2015 – Recognizing that heart health is one of the world’s most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women’s Hospital (BWH), a teaching affiliate of Harvard Medical School, launched a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health. Ancillary studies will focus on a broad range of potential benefits of cocoa flavanols on brain health, including memory, decision-making skills, mood, and cognitive performance, as well as metabolic health.


According to JoAnn Manson, MD, Chief of the Division of Preventive Medicine at BWH and co-lead on the study, “The COSMOS trial builds on a decade of scientific evidence indicating that cocoa flavanols improve blood vessel function, metabolic health, and cognition. The depth and breadth of this innovative trial are unprecedented. ”
Watch Dr. Manson explain why the COSMOS study is a novel and important trial.

This randomized placebo-controlled trial, called the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), will enroll 18,000 women and men nationwide, making it the largest dietary intervention study to evaluate the health benefits of cocoa flavanols and a multivitamin. The study is the result of an innovative public-private partnership among BWH, Harvard Medical School, the Seattle-based Fred Hutchinson Cancer Research Center (FHCRC), the National Institutes of Health (NIH), Mars, Incorporated and Pfizer Inc.

For the past 20 years, Mars, Incorporated and its network of collaborators have built an international research network aimed at pioneering and sharing leading science and innovation to advance the understanding of cocoa flavanols and their impact on human health. Mars, Incorporated is providing financial infrastructure support together with the Heart, Lung and Blood Institute of the NIH, as well as the cocoa flavanol-containing capsules for use in this trial. The capsules are prepared specifically for research purposes and are produced using Mars’ proprietary Cocoapro® process to extract flavanols from cocoa beans.


Dubbed COSMOS (Cocoa Flavanol Supplement and Multivitamin Outcomes Study), this randomized placebo-controlled trial is the largest dietary intervention study to date investigating the health benefits of flavonoids. It is the result of an innovative public-private partnership among BWH, Harvard Medical School, the National Institutes of Health (NIH), the Seattle-based Fred Hutchinson Cancer Research Center, Pfizer and Mars, Incorporated. Credit: Mars, Incorporated

“Our research group has extensive experience in evaluating the impact of large-scale dietary interventions on cardiovascular health,” explained JoAnn Manson, MD, Chief of the Division of Preventive Medicine at BWH and co-lead on the study. “The COSMOS trial builds on a decade of scientific evidence indicating that cocoa flavanols improve blood vessel function, metabolic health and cognition. The depth and breadth of this innovative trial are unprecedented. ”

Howard Sesso, ScD, also from the Division of Preventive Medicine at BWH and co-lead on the study, added, “This is an exciting time for nutritional intervention research, as cocoa flavanols are among the most promising bioactives based on research to date.”

Women in the trial will be recruited from the nationwide Women’s Health Initiative starting in May 2015, and men will be recruited from other large population-based studies conducted through the BWH Division of Preventive Medicine. Others interested in participating can call 1-800-633-6913 (to be eligible, men must be at least 60 and women at least 65 years of age). The partnership among academic hospitals, NIH and the industry is expected to begin to yield answers to its scientific questions by 2019.

“Mars has a long-term commitment to cocoa flavanol research,” noted Dr. Hagen Schroeter, Director of Fundamental Health & Nutrition Research, Mars, Incorporated. “We take a multidisciplinary approach to research and collaborate with a broad platform of top researchers and scientific institutions around the world from government and academia. We believe that this collaboration represents the best of a public-private partnership intended to address one of society’s most significant health challenges.”

COSMOS will also explore the effect of a daily multivitamin on lowering the risk of cancer, following up on promising trial findings reported among men from the Physicians’ Health Study II. It is the first large-scale randomized trial testing of multivitamins in women.

About Mars Center For Cocoa Health Science

For more than 20 years, and based on collaborating with a multidisciplinary group of international experts, Mars, Incorporated has been conducting comprehensive and innovative research with a network of scientific collaborators around the world to advance the understanding of cocoa flavanols and their health benefits for the purpose of improving human health. Building on decades of research in cocoa flavanols, the Mars Center for Cocoa Health Science (MCCHS) was formally established in 2012 as a Center of Excellence to pioneer, capture and share the latest scientific research in the field. MCCHS provides access to more than 20 years of gold standard research, over 140 published peer-reviewed scientific papers, videos, slides and other information that Mars, Incorporated and its collaborators have developed to advance cocoa flavanol understanding. For more information, please visit http://www.marscocoascience.com. Follow us: http://twitter.com/CocoaHealthSci

About Mars, Incorporated

In 1911, Frank C. Mars made the first Mars candies in his Tacoma, Washington kitchen and established Mars’ first roots as a confectionery company. In the 1920s, Forrest E. Mars, Sr. joined his father in business and together they launched the MILKY WAY® bar. In 1932, Forrest, Sr. moved to the United Kingdom with a dream of building a business based on the objective of creating a “mutuality of benefits for all stakeholders” – this objective serves as the foundation of Mars, Incorporated today. Based in McLean, Virginia, Mars has net sales of more than $33 billion, six business segments including Petcare, Chocolate, Wrigley, Food, Drinks, Symbioscience, and more than 75,000 Associates worldwide that are putting its Principles into action to make a difference for people and the planet through its performance.
For more information, please visit www.mars.com. Follow us: http://facebook.com/mars, http://twitter.com/marsglobal, http://youtube.com/mars, http://linkedin.com/company/mars

 

# # #